We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+10.03%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$55B
AUM Growth
+$6.6B
Cap. Flow
+$2.65B
Cap. Flow %
4.81%
Top 10 Hldgs %
35.14%
Holding
929
New
47
Increased
589
Reduced
189
Closed
58

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$255M
2
AAPL icon
Apple
AAPL
+$173M
3
MSFT icon
Microsoft
MSFT
+$166M
4
JPM icon
JPMorgan Chase
JPM
+$134M
5
AMZN icon
Amazon
AMZN
+$101M

Top Sells

Rank Stock Value
1
OTIS icon
Otis Worldwide
OTIS
+$74.8M
2
ACN icon
Accenture
ACN
+$70.7M
3
ELV icon
Elevance Health
ELV
+$69.2M
4
HES
Hess
HES
+$59.9M
5
MSI icon
Motorola Solutions
MSI
+$53.7M

Sector Composition

Rank Sector Weight
1 Technology 34.07%
2 Financials 13.98%
3 Consumer Discretionary 10.82%
4 Communication Services 10.11%
5 Healthcare 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LNTH icon
801
Lantheus
LNTH
$6.82B
$454K ﹤0.01%
8,859
+2,844
+47% +$178K
SPSC icon
802
SPS Commerce
SPSC
$2.25B
$453K ﹤0.01%
4,352
+1,023
+31% +$122K
APAM icon
803
Artisan Partners
APAM
$2.79B
$452K ﹤0.01%
10,425
-835
-7% -$38.5K
XPEL icon
804
XPEL
XPEL
$1.18B
$452K ﹤0.01%
13,655
+886
+7% +$31.4K
EPAM icon
805
EPAM Systems
EPAM
$4.69B
$450K ﹤0.01%
2,987
-1,796
-38% -$295K
HCKT icon
806
Hackett Group
HCKT
$245M
$450K ﹤0.01%
23,672
+4,567
+24% +$99.8K
WDFC icon
807
WD-40
WDFC
$3.1B
$449K ﹤0.01%
2,272
+349
+18% +$75.6K
YETI icon
808
Yeti Holdings
YETI
$3.82B
$449K ﹤0.01%
13,527
-1,775
-12% -$62K
CRMD icon
809
CorMedix
CRMD
$617M
$442K ﹤0.01%
+38,030
New +$460K
DAVE icon
810
Dave Inc
DAVE
$5.12B
$441K ﹤0.01%
2,211
-177
-7% -$38.2K
YOU icon
811
Clear Secure
YOU
$5.26B
$438K ﹤0.01%
13,125
-5,633
-30% -$187K
CRVL icon
812
CorVel
CRVL
$3.05B
$438K ﹤0.01%
5,657
+1,347
+31% +$120K
IPAR icon
813
Interparfums
IPAR
$3.92B
$437K ﹤0.01%
4,445
+886
+25% +$104K
HLNE icon
814
Hamilton Lane
HLNE
$3.63B
$435K ﹤0.01%
3,225
+116
+4% +$17.5K
ADMA icon
815
ADMA Biologics
ADMA
$1.92B
$434K ﹤0.01%
29,613
+5,492
+23% +$94.1K
ACAD icon
816
Acadia Pharmaceuticals
ACAD
$4.25B
$432K ﹤0.01%
20,253
-877
-4% -$20.7K
TREX icon
817
Trex
TREX
$4.51B
$431K ﹤0.01%
8,338
– –
AUPH icon
818
Aurinia Pharmaceuticals
AUPH
$1.97B
$427K ﹤0.01%
+38,676
New +$422K
FE icon
819
FirstEnergy
FE
$28.9B
$426K ﹤0.01%
9,294
– –
CNP icon
820
CenterPoint Energy
CNP
$29.1B
$417K ﹤0.01%
10,746
– –
HRMY icon
821
Harmony Biosciences
HRMY
$2.04B
$413K ﹤0.01%
14,992
+1,333
+10% +$45.9K
DOX icon
822
Amdocs
DOX
$5.53B
$403K ﹤0.01%
4,912
-727
-13% -$63K
CART icon
823
Maplebear
CART
$9.92B
$399K ﹤0.01%
10,855
+382
+4% +$17.6K
MGM icon
824
MGM Resorts International
MGM
$11.7B
$398K ﹤0.01%
11,493
+2,267
+25% +$83.2K
IDT icon
825
IDT Corp
IDT
$1.6B
$397K ﹤0.01%
7,596
+29
+0.4% +$1.81K
31 32
33
34 35

Similar funds

Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Aviva's Q3 2025 Portfolio in Review

As of Q3 2025, Aviva held 929 positions worth $55B, up 14% from $48.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Aviva deployed $2.65B of net new capital in Q3 2025, opening 47 new positions and adding to 589 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Otis Worldwide, an estimated $74.8M trimmed.

  • Aviva's largest Q3 2025 buy was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.
  • Aviva added most to NVIDIA in Q3 2025, an estimated $255M increase.
  • Aviva's biggest Q3 2025 reduction was Otis Worldwide, cutting an estimated $74.8M.
  • Aviva fully exited Hess in Q3 2025, selling an estimated $59.9M.
  • Aviva's ten largest holdings make up 35% of its $55B portfolio in Q3 2025.
  • Aviva opened 47 new positions and closed 58 in Q3 2025.
  • Aviva's portfolio value rose 14% quarter-over-quarter to $55B.

Based on Aviva's 13F filing for Q3 2025, filed 13 Nov 2025.